- Report
- December 2023
- 200 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- November 2023
- 143 Pages
Global
From €2414EUR$2,499USD£2,064GBP
- Report
- May 2024
- 510 Pages
Global
From €5265EUR$5,450USD£4,502GBP
- Report
- March 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- November 2023
- 179 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- February 2024
- 120 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- October 2023
- 170 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- February 2024
- 110 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 110 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 115 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- October 2023
- 82 Pages
United States
From €3381EUR$3,500USD£2,891GBP
- Report
- February 2024
- 80 Pages
Europe
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4588EUR$4,750USD£3,923GBP
- Report
- October 2023
- 95 Pages
Europe
From €2029EUR$2,100USD£1,735GBP
€2898EUR$3,000USD£2,478GBP
- Report
- October 2023
- 91 Pages
Asia Pacific
From €2029EUR$2,100USD£1,735GBP
€2898EUR$3,000USD£2,478GBP
- Report
- February 2022
- 216 Pages
Global
From €5071EUR$5,250USD£4,336GBP
- Report
- June 2022
- 225 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- October 2021
- 182 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- October 2021
- 61 Pages
Global
From €4782EUR$4,950USD£4,089GBP
The Neurodegenerative Disease market is a subset of the Neurosciences field that focuses on the diagnosis, treatment, and prevention of diseases that cause the progressive loss of structure or function of neurons, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). These diseases are characterized by the gradual degeneration of the nervous system, leading to a decline in cognitive and motor functions. Treatment options for these diseases are limited, and there is currently no cure.
The Neurodegenerative Disease market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, medical device companies, and research organizations. Examples of companies in this market include AbbVie, Biogen, Novartis, Merck, and Pfizer. Show Less Read more